CLPH-211

N/A

Report date: 2025/01/03 16:39:20

Base Information

Drug NameCLPH-211
Drug Alias NameCLPH-211
ClassificationBiologics
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsBlood Loss, Surgical
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryDenmark
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesCellphire Therapeutics Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsBlood Loss, Surgical
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A